Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The role of IL-17 and anti-IL-17 agents in the immunopathogenesis and management of autoimmune and inflammatory diseases.
Int Immunopharmacol. 2022 Jan;102:108402. doi: 10.1016/j.intimp.2021.108402. Epub 2021 Dec 1.
Int Immunopharmacol. 2022.
PMID: 34863654
Review.
A randomized phase I pharmacokinetic trial comparing the potential biosimilar adalimumab (CinnoRA®) with the reference product (Humira®) in healthy volunteers.
Jamshidi A, Sabzvari A, Anjidani N, Shahpari R, Badri N.
Jamshidi A, et al. Among authors: sabzvari a.
Expert Opin Investig Drugs. 2020 Mar;29(3):327-331. doi: 10.1080/13543784.2020.1723000. Epub 2020 Jan 30.
Expert Opin Investig Drugs. 2020.
PMID: 31985294
Clinical Trial.
Item in Clipboard
A Phase IV Study of the Safety and Efficacy of CinnoPar® in Iranian Patients with Osteoporosis.
Jamshidi A, Gharibdoost F, Sedighi S, Hajiabbasi A, Salari AH, Khabbazi A, Mottaghi P, Tahammoli Roudsari A, Aghaei M, Shenavar Masooleh I, Sabzvari A, Anjidani N.
Jamshidi A, et al. Among authors: sabzvari a.
J Osteoporos. 2021 May 31;2021:7584308. doi: 10.1155/2021/7584308. eCollection 2021.
J Osteoporos. 2021.
PMID: 34194720
Free PMC article.
Item in Clipboard
Safety and immunogenicity of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 spike protein vaccine: a phase 2 randomized placebo-controlled trial in both seropositive and seronegative populations.
Tabarsi P, Anjidani N, Shahpari R, Mardani M, Sabzvari A, Yazdani B, Roshanzamir K, Bayatani B, Taheri A, Petrovsky N, Li L, Barati S.
Tabarsi P, et al. Among authors: sabzvari a.
Clin Microbiol Infect. 2022 Sep;28(9):1263-1271. doi: 10.1016/j.cmi.2022.04.004. Epub 2022 Apr 15.
Clin Microbiol Infect. 2022.
PMID: 35436611
Free PMC article.
Clinical Trial.
Item in Clipboard
Evaluating the efficacy and safety of SpikoGen®, an Advax-CpG55.2-adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized placebo-controlled trial.
Tabarsi P, Anjidani N, Shahpari R, Mardani M, Sabzvari A, Yazdani B, Kafi H, Fallah N, Ebrahimi A, Taheri A, Petrovsky N, Barati S.
Tabarsi P, et al. Among authors: sabzvari a.
Clin Microbiol Infect. 2023 Feb;29(2):215-220. doi: 10.1016/j.cmi.2022.09.001. Epub 2022 Sep 10.
Clin Microbiol Infect. 2023.
PMID: 36096430
Free PMC article.
Clinical Trial.
Item in Clipboard
Evaluating the Efficacy and Safety of Aflibercept Biosimilar (P041) Compared with Originator Product in Patients with Neovascular Age-Related Macular Degeneration.
Karkhaneh R, Faghihi H, Riazi-Esfahani H, Abrishami M, Bazvand F, Ebrahimiadib N, Johari M, Akhlaghi M, Shoeibi N, Norouzzadeh MH, Ansari Astaneh MR, Khojasteh H, Imani Fooladi M, Khodabande A, Ghassemi F, Khalili Pour E, Zarei M, Mirshahi A, Fazel F, Ashraf H, Hosseini SM, Dourandeesh M, Feghhi M, Alizadeh Y, Behboudi H, Azadi P, Sabzvari A, Kafi H, Ghasemi Falavarjani K.
Karkhaneh R, et al. Among authors: sabzvari a.
Ophthalmol Retina. 2024 Feb 28:S2468-6530(24)00081-2. doi: 10.1016/j.oret.2024.02.012. Online ahead of print.
Ophthalmol Retina. 2024.
PMID: 38428459
Item in Clipboard
Cite
Cite